Navigation Links
A Screen of shRNAs Targeting Tumor Suppressor Genes to Identify Factors Involved in Paclitaxel Sensitivity

atients with tumors containing high levels of some genes, such as p53, would be expected to respond less well to paclitaxel, perhaps falling into the group of 80% non-responders, while patients with low levels of other genes, such as VHL, would be expected to respond better to this drug (perhaps falling into the 20% clinical responder population).

An advantage to the use of shRNA is that it allows an investigator to rapidly validate results in multiple model systems. We are encouraged by our findings in this one non-small cell lung carcinoma line and want to attempt to validate the results in additional lines. We are similarly interested in determining whether these genes play a role only in NSCLC, or if they also affect response rates in cell lines derived from other tumor types. We can do this fairly simply with lentiviral delivery of shRNA with little, or no, additional optimization of conditions necessary. Unlike the more traditional siRNA approach, we do not need to optimize transfection or reaction conditions for each new cell line transduction is usually as simple as growing cells and adding lentivirus to the media. Also unlike siRNA, shRNA allows one to have a long-term down-regulation of a gene. This will facilitate our moving from an in vitro setting to an in vivo experiment. After confirmation of our results in mouse xenograft models, we hope to examine the clinical setting to see if patients who have been treated with paclitaxel in the past have a gene expression profile correlating with our findings. If so, these elucidated genes will have exciting possibilities, either as targets or biomarkers for paclitaxel sensitivity.

For more information on the MISSION TRC shRNA collections, visit sigma-aldrich.com/rnai.

Figure 1
'"/>

Source:


Page: All 1 2 3 4 5 6

Related biology technology :

1. Innovative Tissue Array Technology for High-Throughput Screening of Gene Expression
2. Screening of Beer-Spoilage Bacteria Using the LightCycler PCR Workflow System
3. LightCycler foodproof Beer Screening Kit
4. Perform RNAi Library Screens on Any Budget
5. Recommendations for Successful siRNA Library Screens
6. Setting up Successful siRNA Library Screens
7. Temporal Temperature Gradient Electrophoresis: A Powerful Technique to Screen Mutations
8. Development of a Multiplex Bead-Based Assay for Antibody Screening of a Nonhuman Primate Colony on the Bio-Plex System
9. Screening for potential beta 2-adrenergic receptor antagonists using CypHer5E and IN Cell Analyzer 1000
10. Screening for β2-adrenergic receptor agonists using the pH-sensitive dye,CypHer5, and the IN Cell Analyzer 3000
11. A Mix-and-Read Cell-Based Assay for Hybridoma Screening Using the FMAT 8100 HTS System
Post Your Comments:
(Date:7/29/2015)... ... July 29, 2015 , ... ... a Silicon Valley-based CRO specializing in Clinical Trial Management. CSSi LifeSciences is ... services. The core expertise of PRC Clinical is focused on Clinical Trial Management, ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... the company is making good progress in evaluating the full range of capabilities ... stem cells. Adult tissue stem cells perform the day-to-day renewal and repair of ...
(Date:7/28/2015)... Ashland, Virginia (PRWEB) , ... July 29, 2015 , ... The new Xsample 530 ... refractometer. It handles a wide range of liquid viscosities – from less than 12,000 mPas ... in 12 mL vials. , What immediately catches the eye about Xsample 530 is ...
(Date:7/28/2015)... ... 2015 , ... In terms of value, aluminium hydroxide production ... reached close to 1.84 million tonnes in the same year. As of 2013, ... region’s total aluminium hydroxide production; the country’s aluminium hydroxide production posted a 101.8% ...
Breaking Biology Technology:CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 2CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 3Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 2Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 3Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 4New Moves in Automatic Sample Handling: Introducing Xsample 530 2EU27 Aluminium Hydroxide Market Analysed and Forecast by BAC Reports in New Research Study Available at MarketPublishers.com 2EU27 Aluminium Hydroxide Market Analysed and Forecast by BAC Reports in New Research Study Available at MarketPublishers.com 3
... Bahamas, May 1 Fincor (Pink Sheets: FINC) ... Sheets: PRPG) , a leading company in the field of ... and Dengue fever treatment. Fincor also acquired the WETTECH and ... International Inc., which combines several natural drugs to fight Malaria ...
... and Adds A New MemberCAMBRIDGE, Mass., May 1 ... Maureen Lister was appointed president of the ALS Therapy ... its Board of Directors. The two appointments come following ... due to complications from Lou Gehrig,s disease (ALS) this ...
... Street,s best month in nine years, which analysts believe sends ... begin a turnaround. The Dow Jones industrial average provided an ... a 7.7 percent gain in March and the Nasdaq was ... by a World Health Organization warning that a flu pandemic ...
Cached Biology Technology:Fincor (FINC) Makes a Share Transfer and Enters the Market With ACTRx a New Malaria and Dengue Fever Treatment 2ALS Therapy Development Institute, the World's Largest Non-Profit Biotech, Appoints Steve Perrin, Ph.D., as Chief Executive Officer 2ALS Therapy Development Institute, the World's Largest Non-Profit Biotech, Appoints Steve Perrin, Ph.D., as Chief Executive Officer 3Biotech Drops on Weaker First Quarter Drug Sales, But Broader Markets Remain on a Roll 2Biotech Drops on Weaker First Quarter Drug Sales, But Broader Markets Remain on a Roll 3
(Date:6/30/2015)... , June 30, 2015 To bolster its efforts ... HYPR Corp. announced today the addition of two new team ... as board advisor and David Raviv will act ... underscore HYPR Corp.,s commitment to providing the most secure solutions ... Sirota co-founded Layer 7 Technologies, a provider of security ...
(Date:6/29/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/zj7h4f/latin_america ) ... Biomedical Sensors Market - Growth, Trends & Forecasts (2014-2020)" ... America Biomedical Sensors market is estimated at $0.65 billion ... period 2014-2020 The near future will bring ... of each individual. These sensors can be set to ...
(Date:6/25/2015)... DALLAS , June 25, 2015 ... report "Fingerprint Sensors Market by Type (Swipe & Area), Technology, ... (Mobile, Government, Healthcare, Commercial Security & Others) & ... published by marketsandmarkets, the said market is expected ... CAGR of 17.1%. Browse 76 ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3Latin America Biomedical Sensors Market Report 2015-2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4
... week,s issue of "New Scientist" magazine, research by Rice University ... on one,s mind about politics may be influenced by how ... topic for a number of years, and his team analyzed ... the United States and supplemented it with findings from twins ...
... around the time of the dinosaurs, demise, or have ... is at the center of a sometimes contentious "rocks ... on the fossil record, and scientists who use "molecular ... analysis by researchers at the University of Michigan, the ...
... NEW YORK CITY Dr. Andrew Constable of ... at the Antarctic Climate and Ecosystems Cooperative Research ... 2008 Pew Fellowship in Marine Conservation to help ... will create sophisticated ecosystem-based management plans for these ...
Cached Biology News:Avian origins: new analysis confirms ancient beginnings 2Dr. Andrew Constable awarded 2008 Pew Fellowship in marine conservation 2Dr. Andrew Constable awarded 2008 Pew Fellowship in marine conservation 3
... Diagnostics Cytomegalovirus (CMV) pp65 Antigenemia Immunofluorescence Assay ... of lower matrix protein pp65 of CMV ... Components: Erythrocyte Lysis ... containing 220 mL of buffered ammonium chloride. ...
CHIMAERIC HUMAN IgA2 ANTI NP...
... suspension (non-adherent) cells, RNA ture ... or centrifugation to separate cells ... with 96-well GenePlate®. RiboCap™ plates ... sizes and contain the appropriate ...
nuclear cap binding protein subunit 1, 80kDa, mRNA...
Biology Products: